{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:40:56Z","timestamp":1792194056070,"version":"4.4.0"},"reference-count":267,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hubei Provincial Natural Science Foundation Innovation and Development Joint Fund"},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer progression does not occur in isolation: malignant-cell states and fates are shaped by specialized microenvironments, or cancer niches. Within primary tumors, vascular, stromal, immune and neural interactions create local hypoxic, metabolic and mechanical conditions that together influence malignant-cell behavior. These local environments sustain stem-like states, regulate immune surveillance and vascular remodeling, and influence dissemination and treatment response. Tumor-derived extracellular vesicles and other systemic signals connect primary tumors to distant organs, conditioning tissues before tumor-cell arrival and subsequently modulating disseminated tumor-cell seeding, dormancy, reactivation and outgrowth. Cancer niches therefore operate across spatial scales and disease stages, shaping tumor behavior in ways that cannot be explained by tumor-cell-intrinsic properties alone. Advances in single-cell and spatial profiling, organoid systems and intravital imaging are revealing their cellular composition, local architecture and evolution. In this review, we integrate primary, pre-metastatic and metastatic niche biology, examine how local environments evolve and influence one another during cancer progression, compare organ-specific metastatic niches and assess emerging therapeutic strategies. Effective niche-directed therapy will require identifying the interactions that sustain disease, showing that treatment disrupts them and determining which patients are most likely to benefit. Greater spatial, temporal and functional resolution may reveal new therapeutic vulnerabilities and create opportunities to prevent relapse and achieve more durable disease control.<\/jats:p>","DOI":"10.1186\/s13045-026-01858-8","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:02:28Z","timestamp":1792166548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Niches in cancer: from primary tumors to metastatic disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Zheng","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-1457","authenticated-orcid":false,"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1858_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF00176898","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"1858_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841\u20136.","journal-title":"Nature"},{"key":"1858_CR3","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836\u201341.","journal-title":"Nature"},{"key":"1858_CR4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41:546\u201372.","journal-title":"Cancer Cell"},{"key":"1858_CR5","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.cell.2026.03.003","volume":"189","author":"DF Quail","year":"2026","unstructured":"Quail DF, Joyce JA. Cancer ecosystems: A dynamic interplay across scales. Cell. 2026;189:2441\u201363.","journal-title":"Cell"},{"key":"1858_CR6","doi-asserted-by":"crossref","first-page":"101872","DOI":"10.1016\/j.xcrm.2024.101872","volume":"6","author":"I Miranda","year":"2025","unstructured":"Miranda I, Jahan N, Shevde LA. The metastatic cascade through the lens of therapeutic inhibition. Cell Rep Med. 2025;6:101872.","journal-title":"Cell Rep Med"},{"key":"1858_CR7","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41467-020-18860-4","volume":"11","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhou C, Zhang Z, Wang Q, Wei H, Shi W, et al. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1. Nat Commun. 2020;11:5129.","journal-title":"Nat Commun"},{"key":"1858_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41586-022-05242-7","volume":"610","author":"P Karras","year":"2022","unstructured":"Karras P, Bordeu I, Pozniak J, Nowosad A, Pazzi C, Van Raemdonck N, et al. A cellular hierarchy in melanoma uncouples growth and metastasis. Nature. 2022;610:190\u201398.","journal-title":"Nature"},{"key":"1858_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18:36.","journal-title":"J Hematol Oncol"},{"key":"1858_CR10","doi-asserted-by":"crossref","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"},{"key":"1858_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","volume":"25","author":"T Wertheimer","year":"2024","unstructured":"Wertheimer T, Zwicky P, Rindlisbacher L, Sparano C, Vermeer M, de Melo BMS, et al. IL-23 stabilizes an effector T(reg) cell program in the tumor microenvironment. Nat Immunol. 2024;25:512\u201324.","journal-title":"Nat Immunol"},{"key":"1858_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2025.11.020","volume":"59","author":"B Zitti","year":"2026","unstructured":"Zitti B, Duval F, Wirapati P, Hicham M, Xie Y, Oh J, et al. Positioning and reversible suppression of CCR7(+) dendritic cells in perivascular tumor niches shape cancer immunity. Immunity. 2026;59:161\u2013e7612.","journal-title":"Immunity"},{"key":"1858_CR13","doi-asserted-by":"crossref","first-page":"e183366","DOI":"10.1172\/JCI183366","volume":"134","author":"D Song","year":"2024","unstructured":"Song D, Wu Y, Li J, Liu J, Yi Z, Wang X, et al. Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy. J Clin Invest. 2024;134:e183366.","journal-title":"J Clin Invest"},{"key":"1858_CR14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk. Cancer Res. 2021;81:1431\u201340.","journal-title":"Cancer Res"},{"key":"1858_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-025-01748-5","volume":"18","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo X, Liu P, Wang Y, Zhang J, Li L, et al. The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities. J Hematol Oncol. 2025;18:93.","journal-title":"J Hematol Oncol"},{"key":"1858_CR16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/cancers14051259","volume":"14","author":"L Davis","year":"2022","unstructured":"Davis L, Recktenwald M, Hutt E, Fuller S, Briggs M, Goel A, et al. Targeting HIF-2alpha in the Tumor Microenvironment: Redefining the Role of HIF-2alpha for Solid Cancer Therapy. Cancers (Basel). 2022;14:1259.","journal-title":"Cancers (Basel)"},{"key":"1858_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tibs.2025.06.005","volume":"50","author":"K Acuna-Pilarte","year":"2025","unstructured":"Acuna-Pilarte K, Koh MY. The HIF axes in cancer: angiogenesis, metabolism, and immune-modulation. Trends Biochem Sci. 2025;50:677\u201394.","journal-title":"Trends Biochem Sci"},{"key":"1858_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2010.05.021","volume":"7","author":"SJ Curtis","year":"2010","unstructured":"Curtis SJ, Sinkevicius KW, Li D, Lau AN, Roach RR, Zamponi R, et al. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell. 2010;7:127\u201333.","journal-title":"Cell Stem Cell"},{"key":"1858_CR19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/cancers14040976","volume":"14","author":"B Aramini","year":"2022","unstructured":"Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, et al. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel). 2022;14:976.","journal-title":"Cancers (Basel)"},{"key":"1858_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A Perez-Gonzalez","year":"2023","unstructured":"Perez-Gonzalez A, Bevant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat Cancer. 2023;4:1063\u201382.","journal-title":"Nat Cancer"},{"key":"1858_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820\u20137.","journal-title":"Nature"},{"key":"1858_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17:302\u201317.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41568-024-00752-0","volume":"24","author":"N Rabas","year":"2024","unstructured":"Rabas N, Ferreira RMM, Di Blasio S, Malanchi I. Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells. Nat Rev Cancer. 2024;24:829\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40164-024-00571-x","volume":"13","author":"SZ Xie","year":"2024","unstructured":"Xie SZ, Yang LY, Wei R, Shen XT, Pan JJ, Yu SZ, et al. Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis. Exp Hematol Oncol. 2024;13:111.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR25","doi-asserted-by":"crossref","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361:eaao4227.","journal-title":"Science"},{"key":"1858_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2022","unstructured":"Di Martino JS, Nobre AR, Mondal C, Taha I, Farias EF, Fertig EJ, et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer. 2022;3:90\u2013107.","journal-title":"Nat Cancer"},{"key":"1858_CR27","doi-asserted-by":"crossref","first-page":"e143765","DOI":"10.1172\/JCI143765","volume":"131","author":"KJ Metcalf","year":"2021","unstructured":"Metcalf KJ, Alazzeh A, Werb Z, Weaver VM. Leveraging microenvironmental synthetic lethalities to treat cancer. J Clin Invest. 2021;131:e143765.","journal-title":"J Clin Invest"},{"key":"1858_CR28","doi-asserted-by":"crossref","first-page":"e143764","DOI":"10.1172\/JCI143764","volume":"131","author":"AM Muscarella","year":"2021","unstructured":"Muscarella AM, Aguirre S, Hao X, Waldvogel SM, Zhang XH. Exploiting bone niches: progression of disseminated tumor cells to metastasis. J Clin Invest. 2021;131:e143764.","journal-title":"J Clin Invest"},{"key":"1858_CR29","doi-asserted-by":"crossref","first-page":"1408750","DOI":"10.3389\/fphys.2024.1408750","volume":"15","author":"S Monaci","year":"2024","unstructured":"Monaci S, Coppola F, Filippi I, Falsini A, Carraro F, Naldini A. Targeting hypoxia signaling pathways in angiogenesis. Front Physiol. 2024;15:1408750.","journal-title":"Front Physiol"},{"key":"1858_CR30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/0008-5472.CAN-23-1418","volume":"84","author":"Y Du","year":"2024","unstructured":"Du Y, Shi J, Wang J, Xun Z, Yu Z, Sun H, et al. Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment. Cancer Res. 2024;84:192\u2013210.","journal-title":"Cancer Res"},{"key":"1858_CR31","doi-asserted-by":"crossref","first-page":"101626","DOI":"10.1016\/j.xcrm.2024.101626","volume":"5","author":"F Mpekris","year":"2024","unstructured":"Mpekris F, Panagi M, Charalambous A, Voutouri C, Stylianopoulos T. Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy. Cell Rep Med. 2024;5:101626.","journal-title":"Cell Rep Med"},{"key":"1858_CR32","doi-asserted-by":"crossref","first-page":"e174092","DOI":"10.1172\/JCI174092","volume":"136","author":"JL Ruiz-Sepulveda","year":"2026","unstructured":"Ruiz-Sepulveda JL, Bueno MJ, Mouron S, Jimenez-Renard V, Munoz M, Moradiellos M, et al. Osteopontin mediates acquired resistance to hypoxia-inducing antiangiogenics and promotes anti-PD-L1 refractoriness in breast cancer models. J Clin Invest. 2026;136:e174092.","journal-title":"J Clin Invest"},{"key":"1858_CR33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1470-2045(21)00151-0","volume":"22","author":"PR Galle","year":"2021","unstructured":"Galle PR, Finn RS, Qin S, Ikeda M, Zhu AX, Kim TY, et al. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial. Lancet Oncol. 2021;22:991\u20131001.","journal-title":"Lancet Oncol"},{"key":"1858_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2025.09.006","volume":"37","author":"RJ Motzer","year":"2026","unstructured":"Motzer RJ, Escudier B, Burotto M, Powles T, Apolo AB, Bourlon MT, et al. Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial. Ann Oncol. 2026;37:33\u201343.","journal-title":"Ann Oncol"},{"key":"1858_CR35","doi-asserted-by":"crossref","first-page":"661838","DOI":"10.3389\/fncel.2021.661838","volume":"15","author":"F Takata","year":"2021","unstructured":"Takata F, Nakagawa S, Matsumoto J, Dohgu S. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Front Cell Neurosci. 2021;15:661838.","journal-title":"Front Cell Neurosci"},{"key":"1858_CR36","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s42003-021-02308-6","volume":"4","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Guo Y, Hao J, Guenter R, Lathia J, Beck AW, et al. Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid\/protein kinase D signaling. Commun Biol. 2021;4:780.","journal-title":"Commun Biol"},{"key":"1858_CR37","first-page":"e56524","volume":"24","author":"Z Wu","year":"2023","unstructured":"Wu Z, Thierry K, Bachy S, Zhang X, Gamradt P, Hernandez-Vargas H, et al. Pericyte stem cells induce Ly6G(+) cell accumulation and immunotherapy resistance in pancreatic cancer. EMBO Rep. 2023;24:e56524.","journal-title":"EMBO Rep"},{"key":"1858_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15:807\u201317.","journal-title":"Nat Cell Biol"},{"key":"1858_CR39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/2159-8290.CD-22-0220","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xu Z, Hao X, He T, Li J, Shen Y, et al. Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2\u2009+\u2009Cells. Cancer Discov. 2023;13:474\u201395.","journal-title":"Cancer Discov"},{"key":"1858_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12032-025-02787-1","volume":"42","author":"SO Rab","year":"2025","unstructured":"Rab SO, Altalbawy FMA, Bishoyi AK, Ballal S, Kareem M, Singh A, et al. Targeting platelet-tumor cell interactions: a novel approach to cancer therapy. Med Oncol. 2025;42:232.","journal-title":"Med Oncol"},{"key":"1858_CR41","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s43018-023-00716-7","volume":"5","author":"M Jakab","year":"2024","unstructured":"Jakab M, Lee KH, Uvarovskii A, Ovchinnikova S, Kulkarni SR, Jakab S, et al. Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency. Nat Cancer. 2024;5:716\u201330.","journal-title":"Nat Cancer"},{"key":"1858_CR42","doi-asserted-by":"crossref","first-page":"e80690","DOI":"10.7554\/eLife.80690","volume":"11","author":"NL Tran","year":"2022","unstructured":"Tran NL, Ferreira LM, Alvarez-Moya B, Buttiglione V, Ferrini B, Zordan P, et al. Continuous sensing of IFN\u03b1 by hepatic endothelial cells shapes a vascular antimetastatic barrier. Elife. 2022;11:e80690.","journal-title":"Elife"},{"key":"1858_CR43","first-page":"0387","volume":"7","author":"J Ye","year":"2024","unstructured":"Ye J, Gao X, Huang X, Huang S, Zeng D, Luo W, et al. Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma. Res (Wash D C). 2024;7:0387.","journal-title":"Res (Wash D C)"},{"key":"1858_CR44","doi-asserted-by":"crossref","first-page":"102395","DOI":"10.1016\/j.xcrm.2025.102395","volume":"6","author":"V Boeker","year":"2025","unstructured":"Boeker V, Kalluri R. Insights into the relevance of targeting fibroblasts to control cancer. Cell Rep Med. 2025;6:102395.","journal-title":"Cell Rep Med"},{"key":"1858_CR45","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1038\/s41598-023-45832-7","volume":"13","author":"R Cai","year":"2023","unstructured":"Cai R, Tressler CM, Cheng M, Sonkar K, Tan Z, Paidi SK, et al. Primary breast tumor induced extracellular matrix remodeling in premetastatic lungs. Sci Rep. 2023;13:18566.","journal-title":"Sci Rep"},{"key":"1858_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, Liu Y, Zhou G. Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol. 2025;18:65.","journal-title":"J Hematol Oncol"},{"key":"1858_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","volume":"23","author":"Z Lin","year":"2024","unstructured":"Lin Z, Li G, Jiang K, Li Z, Liu T. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications. Mol Cancer. 2024;23:191.","journal-title":"Mol Cancer"},{"key":"1858_CR48","doi-asserted-by":"crossref","first-page":"109298","DOI":"10.1016\/j.identj.2025.109298","volume":"76","author":"KK Cedric","year":"2026","unstructured":"Cedric KK, Sun S, Jin D, Bao S, Sun B, Zhou J, et al. LOX From Salivary Adenoid Cystic Carcinoma-Associated Fibroblast Promotes Fibrosis in the Pulmonary Pre-metastatic Niche. Int Dent J. 2026;76:109298.","journal-title":"Int Dent J"},{"key":"1858_CR49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","volume":"55","author":"Z Gong","year":"2022","unstructured":"Gong Z, Li Q, Shi J, Wei J, Li P, Chang CH, et al. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity. 2022;55:1483\u2013e5009.","journal-title":"Immunity"},{"key":"1858_CR50","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41467-020-15188-x","volume":"11","author":"M Pein","year":"2020","unstructured":"Pein M, Insua-Rodriguez J, Hongu T, Riedel A, Meier J, Wiedmann L, et al. Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020;11:1494.","journal-title":"Nat Commun"},{"key":"1858_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1858_CR52","doi-asserted-by":"crossref","first-page":"1594879","DOI":"10.3389\/fimmu.2025.1594879","volume":"16","author":"Q Hu","year":"2025","unstructured":"Hu Q, Chen J, Liu Y, Chen H, Lai H, Jiang L, et al. TSPAN4(+) fibroblasts coordinate metastatic niche assembly through migrasome-driven metabolic reprogramming and stromal-immune crosstalk in pancreatic adenocarcinoma. Front Immunol. 2025;16:1594879.","journal-title":"Front Immunol"},{"key":"1858_CR53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9:274.","journal-title":"Signal Transduct Target Ther"},{"key":"1858_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13:80.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR55","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1186\/s12885-025-15322-2","volume":"25","author":"J Li","year":"2025","unstructured":"Li J, Qi W, Ma L, Tang Z, Yu W, Wang S, et al. The predictive value of intratumoral tertiary lymphoid structures on the response to immunotherapy in cancer patients: a systematic review and meta-analysis. BMC Cancer. 2025;25:1935.","journal-title":"BMC Cancer"},{"key":"1858_CR56","doi-asserted-by":"crossref","first-page":"1142862","DOI":"10.3389\/fimmu.2023.1142862","volume":"14","author":"G Zheng","year":"2023","unstructured":"Zheng G, Lu Y, Yang Z, Chen H, Liang Q, Zhu Q, et al. Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition. Front Immunol. 2023;14:1142862.","journal-title":"Front Immunol"},{"key":"1858_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307\u201325.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR58","doi-asserted-by":"crossref","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","volume":"6","author":"F Peyraud","year":"2025","unstructured":"Peyraud F, Guegan JP, Vanhersecke L, Brunet M, Teyssonneau D, Palmieri LJ, et al. Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside. Med. 2025;6:100546.","journal-title":"Med"},{"key":"1858_CR59","doi-asserted-by":"crossref","first-page":"115572","DOI":"10.1016\/j.ejca.2025.115572","volume":"225","author":"R Vion","year":"2025","unstructured":"Vion R, Roulleaux-Dugage M, Flippot R, Ouali K, Rouanne M, Clatot F, et al. Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy. Eur J Cancer. 2025;225:115572.","journal-title":"Eur J Cancer"},{"key":"1858_CR60","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","volume":"56","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Sautes-Fridman C. Tertiary lymphoid structures and B cells: An intratumoral immunity cycle. Immunity. 2023;56:2254\u201369.","journal-title":"Immunity"},{"key":"1858_CR61","doi-asserted-by":"publisher","first-page":"21530","DOI":"10.1038\/s41598-020-78560-3","volume":"10","author":"Z Lin","year":"2020","unstructured":"Lin Z, Huang L, Li S, Gu J, Cui X, Zhou Y. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure. Sci Rep. 2020;10:21530.","journal-title":"Sci Rep"},{"key":"1858_CR62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","volume":"18","author":"S Deng","year":"2025","unstructured":"Deng S, Chen Y, Song B, Wang H, Huang S, Wu K, et al. Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities. J Hematol Oncol. 2025;18:97.","journal-title":"J Hematol Oncol"},{"key":"1858_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-025-00695-8","volume":"14","author":"M Radandish","year":"2025","unstructured":"Radandish M, Mashhadi N, Aghayan AH, Taghizadeh M, Salehianfard S, Yahyazadeh S, et al. In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy. Exp Hematol Oncol. 2025;14:105.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu M, Ren Y, Ba Y, Liu S, Zuo A, et al. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Mol Cancer. 2024;23:75.","journal-title":"Mol Cancer"},{"key":"1858_CR65","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00262-022-03310-5","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Meng X, Tang X, Zou W, He Y. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Cancer Immunol Immunother. 2023;72:1505\u201321.","journal-title":"Cancer Immunol Immunother"},{"key":"1858_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00262-025-04108-x","volume":"74","author":"NN Dai","year":"2025","unstructured":"Dai NN, Hu MY, Wang JP, Dai ZH, Xu L, Ye TW. Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets. Cancer Immunol Immunother. 2025;74:245.","journal-title":"Cancer Immunol Immunother"},{"key":"1858_CR67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuonc\/noae167","volume":"27","author":"S Shen","year":"2025","unstructured":"Shen S, Cui Y, Li M, Yu K, Zhu Q, Zhang X, et al. Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity. Neuro Oncol. 2025;27:140\u201354.","journal-title":"Neuro Oncol"},{"key":"1858_CR68","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","volume":"23","author":"M Li","year":"2025","unstructured":"Li M, Lu L, Bao Q, Zhou M, Nie B, Liu Y, et al. Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon. J Nanobiotechnol. 2025;23:239.","journal-title":"J Nanobiotechnol"},{"key":"1858_CR69","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1038\/s41467-026-74782-7","volume":"17","author":"K Hosoya","year":"2026","unstructured":"Hosoya K, Ozasa H, Tsuji T, Oi M, Shima Y, Suminaga K, et al. Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8(+) T cell responses and promoting tertiary lymphoid structure formation. Nat Commun. 2026;17:5681.","journal-title":"Nat Commun"},{"key":"1858_CR70","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s43018-026-01188-1","volume":"7","author":"HM Kim","year":"2026","unstructured":"Kim HM, Joglekar T, Cascone T, Bruno TC. The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets. Nat Cancer. 2026;7:1021\u201324.","journal-title":"Nat Cancer"},{"key":"1858_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-025-01731-0","volume":"18","author":"Y Feng","year":"2025","unstructured":"Feng Y, Liu G, Li H, Cheng L. Target neutrophil heterogeneity and plasticity in cancer. J Hematol Oncol. 2025;18:79.","journal-title":"J Hematol Oncol"},{"key":"1858_CR72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Gu Y, Han Y, Zhang Q, Jiang Z, Zhang X, et al. Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. Cancer Cell. 2016;30:243\u201356.","journal-title":"Cancer Cell"},{"key":"1858_CR73","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41590-024-01960-4","volume":"25","author":"NM Haynes","year":"2024","unstructured":"Haynes NM, Chadwick TB, Parker BS. The complexity of immune evasion mechanisms throughout the metastatic cascade. Nat Immunol. 2024;25:1793\u2013808.","journal-title":"Nat Immunol"},{"key":"1858_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"1858_CR75","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41401-024-01304-w","volume":"45","author":"XH Liang","year":"2024","unstructured":"Liang XH, Chen XY, Yan Y, Cheng AY, Lin JY, Jiang YX, et al. Targeting metabolism to enhance immunotherapy within tumor microenvironment. Acta Pharmacol Sin. 2024;45:2011\u201322.","journal-title":"Acta Pharmacol Sin"},{"key":"1858_CR76","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618:467\u201379.","journal-title":"Nature"},{"key":"1858_CR77","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41:573\u201380.","journal-title":"Cancer Cell"},{"key":"1858_CR78","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, et al. Cancer neuroscience: State of the field, emerging directions. Cell. 2023;186:1689\u2013707.","journal-title":"Cell"},{"key":"1858_CR79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tins.2024.11.008","volume":"48","author":"L Jiang","year":"2025","unstructured":"Jiang L, Cai S, Weng Z, Zhang S, Jiang SH. Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer. Trends Neurosci. 2025;48:124\u201339.","journal-title":"Trends Neurosci"},{"key":"1858_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-025-02336-4","volume":"24","author":"S Huang","year":"2025","unstructured":"Huang S, Zhu J, Yu L, Huang Y, Hu Y. Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities. Mol Cancer. 2025;24:133.","journal-title":"Mol Cancer"},{"key":"1858_CR81","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.immuni.2025.04.017","volume":"58","author":"KW Song","year":"2025","unstructured":"Song KW, Lim M, Monje M. Complex neural-immune interactions shape glioma immunotherapy. Immunity. 2025;58:1140\u201360.","journal-title":"Immunity"},{"key":"1858_CR82","doi-asserted-by":"crossref","first-page":"188828","DOI":"10.1016\/j.bbcan.2022.188828","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu J, Chen W, Shen L, Chen Z, Huang J. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim Biophys Acta Rev Cancer. 2022;1877:188828.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1858_CR83","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.cell.2025.09.029","volume":"188","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Guo Y, Liu Z, Sun Y, Yang X, Chen M, et al. Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance. Cell. 2025;188:6754\u2013e7329.","journal-title":"Cell"},{"key":"1858_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611:405\u201312.","journal-title":"Nature"},{"key":"1858_CR85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, Ostendorf BN, Kerner Z, Tavazoie SF. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature. 2024;633:207\u201315.","journal-title":"Nature"},{"key":"1858_CR86","doi-asserted-by":"crossref","first-page":"710899","DOI":"10.3389\/fonc.2021.710899","volume":"11","author":"D Sigorski","year":"2021","unstructured":"Sigorski D, Gulczynski J, Sejda A, Rogowski W, Izycka-Swieszewska E. Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors. Front Oncol. 2021;11:710899.","journal-title":"Front Oncol"},{"key":"1858_CR87","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","volume":"43","author":"MM Chen","year":"2025","unstructured":"Chen MM, Gao Q, Ning H, Chen K, Gao Y, Yu M, et al. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell. 2025;43:1656\u2013e7610.","journal-title":"Cancer Cell"},{"key":"1858_CR88","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41419-019-2030-2","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang L, et al. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis. 2019;10:788.","journal-title":"Cell Death Dis"},{"key":"1858_CR89","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cpt.1894","volume":"108","author":"P Liao","year":"2020","unstructured":"Liao P, Song K, Zhu Z, Liu Z, Zhang W, Li W, et al. Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8(+) T Cells and Inhibiting Tumor AKT\/MAPK Pathway. Clin Pharmacol Ther. 2020;108:606\u201315.","journal-title":"Clin Pharmacol Ther"},{"key":"1858_CR90","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fjaestad","year":"2022","unstructured":"Fjaestad KY, Romer AMA, Goitea V, Johansen AZ, Thorseth ML, Carretta M, et al. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene. 2022;41:1364\u201375.","journal-title":"Oncogene"},{"key":"1858_CR91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, et al. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol. 2024;13:39.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR92","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1038\/s41467-025-65048-9","volume":"16","author":"KY Fjaestad","year":"2025","unstructured":"Fjaestad KY, Johansen AZ, Linder H, Baker KJ, Schattefor M, Czajkowski NK, et al. beta-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells. Nat Commun. 2025;16:10063.","journal-title":"Nat Commun"},{"key":"1858_CR93","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, Tanaka T, Sunagawa M, Takahashi R, Jiang Z, Macchini M, et al. Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness. Cancer Discov. 2018;8:1458\u201373.","journal-title":"Cancer Discov"},{"key":"1858_CR94","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41416-025-03145-8","volume":"133","author":"L Li","year":"2025","unstructured":"Li L, Yin J, Zhang L, Liu W, Niu Y, Wang L, et al. Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor. Br J Cancer. 2025;133:1122\u201336.","journal-title":"Br J Cancer"},{"key":"1858_CR95","doi-asserted-by":"crossref","first-page":"eady1292","DOI":"10.1126\/sciadv.ady1292","volume":"12","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Chen P, Zheng Y, Li M, Zhao L, Fu Z, et al. Oxidation-activated nanotherapy boosts tumor immunity and disrupts tumor-nerve crosstalk to combat bone metastases and cancer pain. Sci Adv. 2026;12:eady1292.","journal-title":"Sci Adv"},{"key":"1858_CR96","doi-asserted-by":"crossref","first-page":"e147276","DOI":"10.1172\/JCI147276","volume":"131","author":"SM Gysler","year":"2021","unstructured":"Gysler SM, Drapkin R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Invest. 2021;131:e147276.","journal-title":"J Clin Invest"},{"key":"1858_CR97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cmet.2026.02.001","volume":"38","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Zhuang W, Zhu H, Meng F, Chen M, Guo Y, et al. Neuroimmunometabolic co-evolution in the tumor micro- and macroenvironment. Cell Metab. 2026;38:655\u201372.","journal-title":"Cell Metab"},{"key":"1858_CR98","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores-Garcia D, Cervantes-Villagrana AR, Garcia-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020;5:99.","journal-title":"Signal Transduct Target Ther"},{"key":"1858_CR99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-022-04799-5","volume":"13","author":"T Qin","year":"2022","unstructured":"Qin T, Xiao Y, Qian W, Wang X, Gong M, Wang Q, et al. HGF\/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR\/NGF axis. Cell Death Dis. 2022;13:387.","journal-title":"Cell Death Dis"},{"key":"1858_CR100","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41388-024-02994-6","volume":"43","author":"K Cheng","year":"2024","unstructured":"Cheng K, Pan J, Liu Q, Ji Y, Liu L, Guo X, et al. Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR-211-5p\/GDNF. Oncogene. 2024;43:1341\u201352.","journal-title":"Oncogene"},{"key":"1858_CR101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13046-023-02894-9","volume":"42","author":"W Dai","year":"2023","unstructured":"Dai W, Wu X, Li J, Tang W, Wang Y, Xu W, et al. Hedgehog-Gli1-derived exosomal circ-0011536 mediates peripheral neural remodeling in pancreatic cancer by modulating the miR-451a\/VGF axis. J Exp Clin Cancer Res. 2023;42:329.","journal-title":"J Exp Clin Cancer Res"},{"key":"1858_CR102","doi-asserted-by":"crossref","first-page":"101532","DOI":"10.1016\/j.xcrm.2024.101532","volume":"5","author":"Y Mori","year":"2024","unstructured":"Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, et al. Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1alpha and tumor progression of clear cell ovarian cancer. Cell Rep Med. 2024;5:101532.","journal-title":"Cell Rep Med"},{"key":"1858_CR103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41419-025-07646-5","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Yu X, Wen L, Wang J, Li Z, Zhang Y, et al. USP9X integrates TGF-beta and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2alpha-maintained stemness. Cell Death Dis. 2025;16:312.","journal-title":"Cell Death Dis"},{"key":"1858_CR104","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/cells14090673","volume":"14","author":"MZ Bakleh","year":"2025","unstructured":"Bakleh MZ, Al Haj Zen A. The Distinct Role of HIF-1alpha and HIF-2alpha in Hypoxia and Angiogenesis. Cells. 2025;14:673.","journal-title":"Cells"},{"key":"1858_CR105","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10456-018-9600-2","volume":"21","author":"M Serocki","year":"2018","unstructured":"Serocki M, Bartoszewska S, Janaszak-Jasiecka A, Ochocka RJ, Collawn JF, Bartoszewski R. miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target. Angiogenesis. 2018;21:183\u2013202.","journal-title":"Angiogenesis"},{"key":"1858_CR106","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/cancers13102418","volume":"13","author":"X Zeng","year":"2021","unstructured":"Zeng X, Ward SE, Zhou J, Cheng ASL. Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives. Cancers (Basel). 2021;13:2418.","journal-title":"Cancers (Basel)"},{"key":"1858_CR107","doi-asserted-by":"crossref","first-page":"e000154","DOI":"10.1136\/bmjonc-2023-000154","volume":"3","author":"BM Ortmann","year":"2024","unstructured":"Ortmann BM. Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity. BMJ Oncol. 2024;3:e000154.","journal-title":"BMJ Oncol"},{"key":"1858_CR108","doi-asserted-by":"crossref","first-page":"e20251009","DOI":"10.1084\/jem.20251009","volume":"223","author":"S Salman","year":"2026","unstructured":"Salman S, Huang TY, Hwang Y, Kumar A, Datan E, Wicks EE, et al. Targeting conserved domains of hypoxia-inducible factors for cancer therapy. J Exp Med. 2026;223:e20251009.","journal-title":"J Exp Med"},{"key":"1858_CR109","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","volume":"18","author":"T Shang","year":"2025","unstructured":"Shang T, Jia Z, Li J, Cao H, Xu H, Cong L, et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol. 2025;18:32.","journal-title":"J Hematol Oncol"},{"key":"1858_CR110","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","volume":"26","author":"TK Choueiri","year":"2020","unstructured":"Choueiri TK, Kaelin WG. Jr. Targeting the HIF2-VEGF axis in renal cell carcinoma. Nat Med. 2020;26:1519\u201330.","journal-title":"Nat Med"},{"key":"1858_CR111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41419-025-07432-3","volume":"16","author":"T Shen","year":"2025","unstructured":"Shen T, Su Y, Wang D, Li G, Liu X, Sun C, et al. HIF2alpha drives ccRCC metastasis through transcriptional activation of methylation-controlled J protein and enhanced prolegumain secretion. Cell Death Dis. 2025;16:93.","journal-title":"Cell Death Dis"},{"key":"1858_CR112","doi-asserted-by":"crossref","first-page":"1701388","DOI":"10.3389\/fonc.2025.1701388","volume":"15","author":"MN Theodoraki","year":"2025","unstructured":"Theodoraki MN, Hofmann L, Bauer H, Fleckner J, Depping R, Idel C, et al. HIF-2alpha accumulation in human monocytes upon transfer of hypoxia-associated miRNAs via plasma-derived small extracellular vesicles from head and neck cancer patients. Front Oncol. 2025;15:1701388.","journal-title":"Front Oncol"},{"key":"1858_CR113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-025-00689-6","volume":"14","author":"R Wang","year":"2025","unstructured":"Wang R, Zhuang J, Zhang Q, Wu W, Yu X, Zhang H, et al. Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. Exp Hematol Oncol. 2025;14:99.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR114","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17:183\u201394.","journal-title":"Nat Cell Biol"},{"key":"1858_CR115","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C, Montoya-Durango DE, Hu X, Yang C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040\u2013e5810.","journal-title":"Cell Metab"},{"key":"1858_CR116","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41586-025-09898-9","volume":"649","author":"KL Abbott","year":"2026","unstructured":"Abbott KL, Subudhi S, Ferreira R, Gultekin Y, Steinbuch SC, Munim MB, et al. Nutrient requirements of organ-specific metastasis in breast cancer. Nature. 2026;649:1292\u2013301.","journal-title":"Nature"},{"key":"1858_CR117","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ccell.2018.10.002","volume":"34","author":"H Wang","year":"2018","unstructured":"Wang H, Tian L, Liu J, Goldstein A, Bado I, Zhang W, et al. The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability. Cancer Cell. 2018;34:823\u2013e397.","journal-title":"Cancer Cell"},{"key":"1858_CR118","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1016\/j.cell.2025.08.013","volume":"188","author":"Y Han","year":"2025","unstructured":"Han Y, Sarkar H, Xu Z, Lopez-Darwin S, Wei Y, Hang X, et al. Tumors hijack macrophages for iron supply to promote bone metastasis and anemia. Cell. 2025;188:6335\u2013e5426.","journal-title":"Cell"},{"key":"1858_CR119","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1038\/s41388-022-02248-3","volume":"41","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Xu S, Wang F, Peng X, Zhang W, Zhan Y, et al. HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps. Oncogene. 2022;41:3719\u201331.","journal-title":"Oncogene"},{"key":"1858_CR120","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.immuni.2026.03.026","volume":"59","author":"P Qian","year":"2026","unstructured":"Qian P, Li Y, Han Y, Xu C, Zou P, Yang F, et al. Palmitic acid reprograms neutrophils to compromise vascular integrity and promote breast cancer lung metastasis. Immunity. 2026;59:1964\u2013e819.","journal-title":"Immunity"},{"key":"1858_CR121","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR122","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/cancers13030491","volume":"13","author":"YFI Setargew","year":"2021","unstructured":"Setargew YFI, Wyllie K, Grant RD, Chitty JL, Cox TR. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. Cancers (Basel). 2021;13:491.","journal-title":"Cancers (Basel)"},{"key":"1858_CR123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s40164-025-00704-w","volume":"14","author":"SA Xie","year":"2025","unstructured":"Xie SA, Li X, Yin MY, Du F, Zhang ST, Zhu ST. Extracellular matrix stiffness reduces DNA 6 ma level to facilitate colorectal cancer progression via disrupting P53 binding to CDKN1A promoter. Exp Hematol Oncol. 2025;14:111.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR124","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10585-024-10325-y","volume":"42","author":"KJ Jasmer","year":"2024","unstructured":"Jasmer KJ, Shanbhag VC, Forti KM, Woods LT, Gudekar NS, Weisman GA, et al. Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells. Clin Exp Metastasis. 2024;42:7.","journal-title":"Clin Exp Metastasis"},{"key":"1858_CR125","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1158\/0008-5472.CAN-22-3707","volume":"83","author":"N Cohen","year":"2023","unstructured":"Cohen N, Mundhe D, Deasy SK, Adler O, Ershaid N, Shami T, et al. Breast Cancer-Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche. Cancer Res. 2023;83:3354\u201367.","journal-title":"Cancer Res"},{"key":"1858_CR126","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s44341-025-00015-5","volume":"2","author":"S Libring","year":"2025","unstructured":"Libring S, Reinhart-King CA. Premetastatic niche mechanics and organotropism in breast cancer. NPJ Biol Phys Mech. 2025;2:11.","journal-title":"NPJ Biol Phys Mech"},{"key":"1858_CR127","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-024-00591-7","volume":"14","author":"H Peng","year":"2025","unstructured":"Peng H, Chao Z, Wang Z, Hao X, Xi Z, Ma S, et al. Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications. Exp Hematol Oncol. 2025;14:4.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR128","doi-asserted-by":"crossref","unstructured":"Tiwary K, Bravo-Cordero JJ. Metastasis on pause: how dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance. Mol Oncol. 2026. https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.70259.","DOI":"10.1002\/1878-0261.70259"},{"key":"1858_CR129","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","volume":"24","author":"Y Pan","year":"2025","unstructured":"Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al. Cancer stem cells and niches: challenges in immunotherapy resistance. Mol Cancer. 2025;24:52.","journal-title":"Mol Cancer"},{"key":"1858_CR130","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20:398\u2013411.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2020.01.013","volume":"26","author":"R Liang","year":"2020","unstructured":"Liang R, Arif T, Kalmykova S, Kasianov A, Lin M, Menon V, et al. Restraining Lysosomal Activity Preserves Hematopoietic Stem Cell Quiescence and Potency. Cell Stem Cell. 2020;26:359\u2013e767.","journal-title":"Cell Stem Cell"},{"key":"1858_CR132","doi-asserted-by":"crossref","first-page":"e2413019","DOI":"10.1002\/advs.202413019","volume":"12","author":"G Zhang","year":"2025","unstructured":"Zhang G, Zhang X, Pan W, Chen X, Wan L, Liu C, et al. Dissecting the Spatial and Single-Cell Transcriptomic Architecture of Cancer Stem Cell Niche Driving Tumor Progression in Gastric Cancer. Adv Sci (Weinh). 2025;12:e2413019.","journal-title":"Adv Sci (Weinh)"},{"key":"1858_CR133","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-026-10344-7","volume":"654","author":"JR Buissant des Amorie","year":"2026","unstructured":"Buissant des Amorie JR, Hageman JH, Brunner SR, van der Horst SEM, Puschhof MC, van Hoeck A, et al. Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers. Nature. 2026;654:229\u201339.","journal-title":"Nature"},{"key":"1858_CR134","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40164-024-00587-3","volume":"13","author":"K Chen","year":"2024","unstructured":"Chen K, Li Y, Ni J, Yang X, Zhou Y, Pang Y, et al. Identification of a novel subtype of SPP1\u2009+\u2009macrophages expressing SIRPalpha: implications for tumor immune evasion and treatment response prediction. Exp Hematol Oncol. 2024;13:119.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","volume":"26","author":"A Fumagalli","year":"2020","unstructured":"Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell. 2020;26:569\u2013e787.","journal-title":"Cell Stem Cell"},{"key":"1858_CR136","doi-asserted-by":"crossref","first-page":"123015","DOI":"10.1016\/j.lfs.2024.123015","volume":"355","author":"MA Sarabia-Sanchez","year":"2024","unstructured":"Sarabia-Sanchez MA, Tinajero-Rodriguez JM, Ortiz-Sanchez E, Alvarado-Ortiz E. Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion. Life Sci. 2024;355:123015.","journal-title":"Life Sci"},{"key":"1858_CR137","doi-asserted-by":"crossref","first-page":"123016","DOI":"10.1016\/j.biomaterials.2024.123016","volume":"316","author":"D Ghoshal","year":"2025","unstructured":"Ghoshal D, Petersen I, Ringquist R, Kramer L, Bhatia E, Hu T, et al. Multi-niche human bone marrow on-a-chip for studying the interactions of adoptive CAR-T cell therapies with multiple myeloma. Biomaterials. 2025;316:123016.","journal-title":"Biomaterials"},{"key":"1858_CR138","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.trecan.2023.06.010","volume":"9","author":"A Nowosad","year":"2023","unstructured":"Nowosad A, Marine JC, Karras P. Perivascular niches: critical hubs in cancer evolution. Trends Cancer. 2023;9:897\u2013910.","journal-title":"Trends Cancer"},{"key":"1858_CR139","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-023-10092-4","volume":"42","author":"F Francescangeli","year":"2023","unstructured":"Francescangeli F, De Angelis ML, Rossi R, Cuccu A, Giuliani A, De Maria R, et al. Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution. Cancer Metastasis Rev. 2023;42:197\u2013215.","journal-title":"Cancer Metastasis Rev"},{"key":"1858_CR140","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10585-026-10396-z","volume":"43","author":"L Blavier","year":"2026","unstructured":"Blavier L, Crnjac A, DeClerck YA. Contribution of tumor-derived extracellular vesicles in the establishment of the pre-metastatic niche: lessons learned from past experimentations and future directions. Clin Exp Metastasis. 2026;43:16.","journal-title":"Clin Exp Metastasis"},{"key":"1858_CR141","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stem.2023.04.005","volume":"30","author":"X Hao","year":"2023","unstructured":"Hao X, Shen Y, Chen N, Zhang W, Valverde E, Wu L, et al. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell. 2023;30:648\u2013e648.","journal-title":"Cell Stem Cell"},{"key":"1858_CR142","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40164-025-00733-5","volume":"15","author":"Q Lan","year":"2026","unstructured":"Lan Q, Xu H, Zeng Y, Liu L, Hu X, Yang Q, et al. PRL-3 up-regulates exosomal ITGalphavbeta5 expression to promote liver pre-metastatic niche formation and colon cancer liver metastasis. Exp Hematol Oncol. 2026;15:6.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR143","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13000-020-00959-3","volume":"15","author":"PK Myint","year":"2020","unstructured":"Myint PK, Park EJ, Gaowa A, Kawamoto E, Shimaoka M. Targeted remodeling of breast cancer and immune cell homing niches by exosomal integrins. Diagn Pathol. 2020;15:38.","journal-title":"Diagn Pathol"},{"key":"1858_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-019-0964-8","volume":"18","author":"M Wu","year":"2019","unstructured":"Wu M, Wang G, Hu W, Yao Y, Yu XF. Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol Cancer. 2019;18:53.","journal-title":"Mol Cancer"},{"key":"1858_CR145","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-018-0846-5","volume":"17","author":"F Qadir","year":"2018","unstructured":"Qadir F, Aziz MA, Sari CP, Ma H, Dai H, Wang X, et al. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation. Mol Cancer. 2018;17:97.","journal-title":"Mol Cancer"},{"key":"1858_CR146","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00262-022-03196-3","volume":"71","author":"M Wang","year":"2022","unstructured":"Wang M, Qin Z, Wan J, Yan Y, Duan X, Yao X, et al. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1(+) fibroblast and CCR8(+) Treg cell interactions. Cancer Immunol Immunother. 2022;71:2717\u201330.","journal-title":"Cancer Immunol Immunother"},{"key":"1858_CR147","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.7150\/ijbs.86767","volume":"19","author":"W Jia","year":"2023","unstructured":"Jia W, Liang S, Lin W, Li S, Yuan J, Jin M, et al. Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-kappaB pathway. Int J Biol Sci. 2023;19:4744\u201362.","journal-title":"Int J Biol Sci"},{"key":"1858_CR148","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816\u201326.","journal-title":"Nat Cell Biol"},{"key":"1858_CR149","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4103\/jcrt.jcrt_749_23","volume":"20","author":"D Zhang","year":"2024","unstructured":"Zhang D, Luo Q, Xiao L, Chen X, Yang S, Zhang S. Exosomes derived from gastric cancer cells promote phenotypic transformation of hepatic stellate cells and affect the malignant behavior of gastric cancer cells. J Cancer Res Ther. 2024;20:1157\u201364.","journal-title":"J Cancer Res Ther"},{"key":"1858_CR150","doi-asserted-by":"crossref","first-page":"e12518","DOI":"10.1002\/jev2.12518","volume":"13","author":"Y Lin","year":"2024","unstructured":"Lin Y, Zheng H, Jia L, Luo Y, Zhang D, An M, et al. Integrin alpha6-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151. J Extracell Vesicles. 2024;13:e12518.","journal-title":"J Extracell Vesicles"},{"key":"1858_CR151","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13048-025-01845-6","volume":"18","author":"G Xie","year":"2025","unstructured":"Xie G, Chen G, Lv W, Tai W, Zhang B, Zhou X. Trophoblast cell surface antigen 2 (TROP2) from ascitic extracellular vesicles drives peritoneal metastasis of ovarian cancer by mesothelial-to-mesenchymal transition. J Ovarian Res. 2025;18:311.","journal-title":"J Ovarian Res"},{"key":"1858_CR152","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.cell.2025.01.025","volume":"188","author":"S Lucotti","year":"2025","unstructured":"Lucotti S, Ogitani Y, Kenific CM, Geri J, Kim YH, Gu J, et al. Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2. Cell. 2025;188:1642\u2013e6124.","journal-title":"Cell"},{"key":"1858_CR153","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood.2019003978","volume":"137","author":"S D\u2019Ambrosi","year":"2021","unstructured":"D\u2019Ambrosi S, Nilsson RJ, Wurdinger T. Platelets and tumor-associated RNA transfer. Blood. 2021;137:3181\u201391.","journal-title":"Blood"},{"key":"1858_CR154","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-025-00676-x","volume":"14","author":"C Cai","year":"2025","unstructured":"Cai C, Liu Y, Lu R, Fan X, Zeng S, Gan P. Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities. Exp Hematol Oncol. 2025;14:83.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR155","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11:125.","journal-title":"J Hematol Oncol"},{"key":"1858_CR156","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/HEP.0000000000000934","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li T, Ding L, Wang J, Chen C, Liu T, et al. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. Hepatology. 2025;81:791\u2013807.","journal-title":"Hepatology"},{"key":"1858_CR157","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1038\/s41467-025-57938-9","volume":"16","author":"M Hergueta-Redondo","year":"2025","unstructured":"Hergueta-Redondo M, Sanchez-Redondo S, Hurtado B, Santos V, Perez-Martinez M, Ximenez-Embun P, et al. The impact of a high fat diet and platelet activation on pre-metastatic niche formation. Nat Commun. 2025;16:2897.","journal-title":"Nat Commun"},{"key":"1858_CR158","doi-asserted-by":"crossref","first-page":"eaau5898","DOI":"10.1126\/scitranslmed.aau5898","volume":"11","author":"AL Papa","year":"2019","unstructured":"Papa AL, Jiang A, Korin N, Chen MB, Langan ET, Waterhouse A, et al. Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models. Sci Transl Med. 2019;11:eaau5898.","journal-title":"Sci Transl Med"},{"key":"1858_CR159","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/cac2.12637","volume":"45","author":"LL Yao","year":"2025","unstructured":"Yao LL, Qin WT, Hu LP, Shi TZ, Yu Yang J, Li Q, et al. Reciprocal tumor-platelet interaction through the EPHB1-EFNB1 axis in the liver metastatic niche promotes metastatic tumor outgrowth in pancreatic ductal adenocarcinoma. Cancer Commun (Lond). 2025;45:143\u201366.","journal-title":"Cancer Commun (Lond)"},{"key":"1858_CR160","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41388-024-03237-4","volume":"44","author":"T Tang","year":"2025","unstructured":"Tang T, Yang T, Xue H, Liu X, Yu J, Liang C, et al. Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene. 2025;44:601\u201317.","journal-title":"Oncogene"},{"key":"1858_CR161","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","volume":"28","author":"MG Best","year":"2015","unstructured":"Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, et al. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell. 2015;28:666\u201376.","journal-title":"Cancer Cell"},{"key":"1858_CR162","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","volume":"18","author":"LC Hofbauer","year":"2021","unstructured":"Hofbauer LC, Bozec A, Rauner M, Jakob F, Perner S, Pantel K. Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol. 2021;18:488\u2013505.","journal-title":"Nat Rev Clin Oncol"},{"key":"1858_CR163","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","volume":"6","author":"RE Coleman","year":"2020","unstructured":"Coleman RE, Croucher PI, Padhani AR, Clezardin P, Chow E, Fallon M, et al. Bone metastases. Nat Rev Dis Primers. 2020;6:83.","journal-title":"Nat Rev Dis Primers"},{"key":"1858_CR164","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay S, Duffy MP, Ahn KJ, Sussman JH, Pang M, Smith D, et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell. 2024;187:3120\u2013e4029.","journal-title":"Cell"},{"key":"1858_CR165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","volume":"27","author":"H Wang","year":"2015","unstructured":"Wang H, Yu C, Gao X, Welte T, Muscarella AM, Tian L, et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015;27:193\u2013210.","journal-title":"Cancer Cell"},{"key":"1858_CR166","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Clezardin","year":"2021","unstructured":"Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101:797\u2013855.","journal-title":"Physiol Rev"},{"key":"1858_CR167","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/s43018-024-00854-6","volume":"5","author":"KN Jackett","year":"2024","unstructured":"Jackett KN, Browne AT, Aber ER, Clements M, Kaplan RN. How the bone microenvironment shapes the pre-metastatic niche and metastasis. Nat Cancer. 2024;5:1800\u201314.","journal-title":"Nat Cancer"},{"key":"1858_CR168","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41422-023-00810-6","volume":"33","author":"Q Wu","year":"2023","unstructured":"Wu Q, Tian P, He D, Jia Z, He Y, Luo W, et al. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches. Cell Res. 2023;33:464\u201378.","journal-title":"Cell Res"},{"key":"1858_CR169","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","volume":"39","author":"Y Kfoury","year":"2021","unstructured":"Kfoury Y, Baryawno N, Severe N, Mei S, Gustafsson K, Hirz T, et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell. 2021;39:1464\u2013e788.","journal-title":"Cancer Cell"},{"key":"1858_CR170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccell.2017.11.002","volume":"32","author":"H Zheng","year":"2017","unstructured":"Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, et al. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell. 2017;32:731\u2013e476.","journal-title":"Cancer Cell"},{"key":"1858_CR171","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","volume":"184","author":"W Zhang","year":"2021","unstructured":"Zhang W, Bado IL, Hu J, Wan YW, Wu L, Wang H, et al. The bone microenvironment invigorates metastatic seeds for further dissemination. Cell. 2021;184:2471\u2013e8620.","journal-title":"Cell"},{"key":"1858_CR172","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41419-025-07845-0","volume":"16","author":"L Cao","year":"2025","unstructured":"Cao L, Li Y, Ou M, Smirnov A, Liu R, Wang T, et al. Mesenchymal stromal cells highly expressing Sca-1 promote breast cancer lung metastasis through recruiting myeloid cells. Cell Death Dis. 2025;16:507.","journal-title":"Cell Death Dis"},{"key":"1858_CR173","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1038\/s41467-021-26460-z","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Li YN, Jia S, Zhu M, Cao L, Tao M, et al. Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nat Commun. 2021;12:6202.","journal-title":"Nat Commun"},{"key":"1858_CR174","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccell.2025.10.004","volume":"44","author":"F Peng","year":"2026","unstructured":"Peng F, Sinjab A, Dai Y, Treekitkarnmongkol W, Yang S, Gomez Bolanos LI, et al. Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions. Cancer Cell. 2026;44:321\u2013e3913.","journal-title":"Cancer Cell"},{"key":"1858_CR175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Bonnardel J, Haest B, Vanderborght B, Wagner C, Remmerie A, et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185:379\u2013e9638.","journal-title":"Cell"},{"key":"1858_CR176","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17:25.","journal-title":"J Hematol Oncol"},{"key":"1858_CR177","doi-asserted-by":"crossref","first-page":"e157937","DOI":"10.1172\/JCI157937","volume":"133","author":"W Liu","year":"2023","unstructured":"Liu W, Zhou X, Yao Q, Chen C, Zhang Q, Ding K, et al. In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis. J Clin Invest. 2023;133:e157937.","journal-title":"J Clin Invest"},{"key":"1858_CR178","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel J, T\u2019Jonck W, Gaublomme D, Browaeys R, Scott CL, Martens L, et al. Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche. Immunity. 2019;51:638\u2013e549.","journal-title":"Immunity"},{"key":"1858_CR179","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-21-0933","volume":"82","author":"MC Heinz","year":"2022","unstructured":"Heinz MC, Peters NA, Oost KC, Lindeboom RGH, van Voorthuijsen L, Fumagalli A, et al. Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage. Cancer Res. 2022;82:1953\u201368.","journal-title":"Cancer Res"},{"key":"1858_CR180","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12935-025-04134-w","volume":"26","author":"B Mirzaahmadi","year":"2025","unstructured":"Mirzaahmadi B, Salahpour-Anarjan F, Mousakhani A, Haddadi P, Nezamdoust FV, Rahbarghazi R, et al. Brain neurovascular unit in response to intra- and extra-central nervous system cancers: implications, mechanisms, and challenges. Cancer Cell Int. 2025;26:40.","journal-title":"Cancer Cell Int"},{"key":"1858_CR181","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26\u201341.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR182","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s43018-023-00519-w","volume":"4","author":"O Adler","year":"2023","unstructured":"Adler O, Zait Y, Cohen N, Blazquez R, Doron H, Monteran L, et al. Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2. Nat Cancer. 2023;4:401\u201318.","journal-title":"Nat Cancer"},{"key":"1858_CR183","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40478-023-01646-2","volume":"11","author":"A Meszaros","year":"2023","unstructured":"Meszaros A, Molnar K, Fazakas C, Nogradi B, Luvi A, Dudas T, et al. Inflammasome activation in peritumoral astrocytes is a key player in breast cancer brain metastasis development. Acta Neuropathol Commun. 2023;11:155.","journal-title":"Acta Neuropathol Commun"},{"key":"1858_CR184","doi-asserted-by":"crossref","unstructured":"Dai J, Cimino PJ, Gouin KH 3rd, Grzelak CA, Barrett A, Lim AR, et al. Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. Nat Cancer. 2022;3:25\u201342.","DOI":"10.1038\/s43018-021-00297-3"},{"key":"1858_CR185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jconrel.2022.07.009","volume":"349","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Zhang Y, Li C, Li X, Chu Y, Guo Q, et al. Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis. J Control Release. 2022;349:520\u201332.","journal-title":"J Control Release"},{"key":"1858_CR186","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2023.07.002","volume":"44","author":"S Suman","year":"2023","unstructured":"Suman S, Markovic SN. Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis. Trends Immunol. 2023;44:724\u201343.","journal-title":"Trends Immunol"},{"key":"1858_CR187","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ccell.2026.01.003","volume":"44","author":"M Haist","year":"2026","unstructured":"Haist M, Baertsch MA, Reticker-Flynn NE, Lu G, Kempchen TN, Chu P, et al. Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance. Cancer Cell. 2026;44:604\u2013e239.","journal-title":"Cancer Cell"},{"key":"1858_CR188","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00018-022-04262-w","volume":"79","author":"L Gillot","year":"2022","unstructured":"Gillot L, Lebeau A, Baudin L, Pottier C, Louis T, Durre T, et al. Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization. Cell Mol Life Sci. 2022;79:295.","journal-title":"Cell Mol Life Sci"},{"key":"1858_CR189","doi-asserted-by":"crossref","first-page":"e1265718","DOI":"10.1080\/2162402X.2016.1265718","volume":"6","author":"C Balsat","year":"2017","unstructured":"Balsat C, Blacher S, Herfs M, Van de Velde M, Signolle N, Sauthier P, et al. A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer. Oncoimmunology. 2017;6:e1265718.","journal-title":"Oncoimmunology"},{"key":"1858_CR190","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-025-02279-w","volume":"24","author":"K Miao","year":"2025","unstructured":"Miao K, Zhang A, Yang X, Zhang Y, Lin A, Wang L, et al. Lymphatic system is the mainstream for breast cancer dissemination and metastasis revealed by single-cell lineage tracing. Mol Cancer. 2025;24:75.","journal-title":"Mol Cancer"},{"key":"1858_CR191","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cortes-Guiral","year":"2021","unstructured":"Cortes-Guiral D, Hubner M, Alyami M, Bhatt A, Ceelen W, Glehen O, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7:91.","journal-title":"Nat Rev Dis Primers"},{"key":"1858_CR192","doi-asserted-by":"crossref","first-page":"eadu5944","DOI":"10.1126\/sciadv.adu5944","volume":"12","author":"K Uno","year":"2026","unstructured":"Uno K, Yoshihara M, Yamakita Y, Kitami K, Iyoshi S, Sugiyama M, et al. Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation. Sci Adv. 2026;12:eadu5944.","journal-title":"Sci Adv"},{"key":"1858_CR193","doi-asserted-by":"publisher","first-page":"11913","DOI":"10.1038\/s41598-020-68639-2","volume":"10","author":"M Asem","year":"2020","unstructured":"Asem M, Young A, Oyama C, ClaureDeLaZerda A, Liu Y, Ravosa MJ, et al. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer. Sci Rep. 2020;10:11913.","journal-title":"Sci Rep"},{"key":"1858_CR194","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-018-0928-8","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Li B, Li Q, Wei S, He Z, Huang X, et al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis. 2018;9:854.","journal-title":"Cell Death Dis"},{"key":"1858_CR195","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang X, Cheng X, Liu Z, Yin Y, Li X, et al. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat Cancer. 2023;4:1138\u201356.","journal-title":"Nat Cancer"},{"key":"1858_CR196","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cei.13594","volume":"205","author":"Z Liu","year":"2021","unstructured":"Liu Z, Mi F, Han M, Tian M, Deng L, Meng N, et al. Bone marrow-derived mesenchymal stem cells inhibit CD8(+) T cell immune responses via PD-1\/PD-L1 pathway in multiple myeloma. Clin Exp Immunol. 2021;205:53\u201362.","journal-title":"Clin Exp Immunol"},{"key":"1858_CR197","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-19-0148","volume":"7","author":"AM Lesokhin","year":"2019","unstructured":"Lesokhin AM, Bal S, Badros AZ. Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma. Cancer Immunol Res. 2019;7:1224\u201329.","journal-title":"Cancer Immunol Res"},{"key":"1858_CR198","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-021-01031-3","volume":"14","author":"Z Ren","year":"2021","unstructured":"Ren Z, Lantermans H, Kuil A, Kraan W, Arenzana-Seisdedos F, Kersten MJ, et al. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma. J Hematol Oncol. 2021;14:11.","journal-title":"J Hematol Oncol"},{"key":"1858_CR199","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41375-023-01896-y","volume":"37","author":"F Cheng","year":"2023","unstructured":"Cheng F, Wang Z, You G, Liu Y, He J, Yang J. Osteocyte-derived exosomes confer multiple myeloma resistance to chemotherapy through acquisition of cancer stem cell-like features. Leukemia. 2023;37:1392\u201396.","journal-title":"Leukemia"},{"key":"1858_CR200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/cells14070474","volume":"14","author":"N Osada","year":"2025","unstructured":"Osada N, Kikuchi J, Matsuoka S, Yasui H, Ikeda S, Takahashi N, et al. c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment. Cells. 2025;14:474.","journal-title":"Cells"},{"key":"1858_CR201","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41591-021-01232-w","volume":"27","author":"YC Cohen","year":"2021","unstructured":"Cohen YC, Zada M, Wang SY, Bornstein C, David E, Moshe A, et al. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing. Nat Med. 2021;27:491\u2013503.","journal-title":"Nat Med"},{"key":"1858_CR202","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2024024590","volume":"144","author":"M John","year":"2024","unstructured":"John M, Helal M, Duell J, Mattavelli G, Stanojkovska E, Afrin N, et al. Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma. Blood. 2024;144:2121\u201335.","journal-title":"Blood"},{"key":"1858_CR203","doi-asserted-by":"publisher","first-page":"13095","DOI":"10.1038\/ncomms13095","volume":"7","author":"X Hu","year":"2016","unstructured":"Hu X, Garcia M, Weng L, Jung X, Murakami JL, Kumar B, et al. Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. Nat Commun. 2016;7:13095.","journal-title":"Nat Commun"},{"key":"1858_CR204","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41598-022-05520-4","volume":"12","author":"C Sui","year":"2022","unstructured":"Sui C, Zilberberg J, Lee W. Microfluidic device engineered to study the trafficking of multiple myeloma cancer cells through the sinusoidal niche of bone marrow. Sci Rep. 2022;12:1439.","journal-title":"Sci Rep"},{"key":"1858_CR205","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.3390\/ijms20246158","volume":"20","author":"CM Neophytou","year":"2019","unstructured":"Neophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. Int J Mol Sci. 2019;20:6158.","journal-title":"Int J Mol Sci"},{"key":"1858_CR206","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR207","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semcancer.2019.09.002","volume":"60","author":"O Hen","year":"2020","unstructured":"Hen O, Barkan D. Dormant disseminated tumor cells and cancer stem\/progenitor-like cells: Similarities and opportunities. Semin Cancer Biol. 2020;60:157\u201365.","journal-title":"Semin Cancer Biol"},{"key":"1858_CR208","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/2159-8290.CD-21-0010","volume":"11","author":"J Massague","year":"2021","unstructured":"Massague J, Ganesh K. Metastasis-Initiating Cells and Ecosystems. Cancer Discov. 2021;11:971\u201394.","journal-title":"Cancer Discov"},{"key":"1858_CR209","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s43018-021-00179-8","volume":"2","author":"AR Nobre","year":"2021","unstructured":"Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang J, et al. Bone marrow NG2(+)\/Nestin(+) mesenchymal stem cells drive DTC dormancy via TGFbeta2. Nat Cancer. 2021;2:327\u201339.","journal-title":"Nat Cancer"},{"key":"1858_CR210","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1016\/j.cell.2024.09.016","volume":"187","author":"E Dalla","year":"2024","unstructured":"Dalla E, Papanicolaou M, Park MD, Barth N, Hou R, Segura-Villalobos D, et al. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell. 2024;187:6631\u2013e4820.","journal-title":"Cell"},{"key":"1858_CR211","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12943-025-02488-3","volume":"24","author":"KA Roquid","year":"2025","unstructured":"Roquid KA, Vucetic A, Dyukova E, Hanssen MJ, Cho H, Bonnavion R, et al. Lung endothelial PEAR1 induces tumor cell dormancy. Mol Cancer. 2025;24:278.","journal-title":"Mol Cancer"},{"key":"1858_CR212","doi-asserted-by":"crossref","first-page":"101220","DOI":"10.1016\/j.neo.2025.101220","volume":"68","author":"L Recalde-Percaz","year":"2025","unstructured":"Recalde-Percaz L, de la Guia-Lopez I, Linzoain-Agos P, Noguera-Castells A, Rodrigo-Faus M, Jauregui P, et al. Neuropilin-2 upregulation by stromal TGFbeta1 induces lung disseminated tumor cells dormancy escape and promotes metastasis outgrowth. Neoplasia. 2025;68:101220.","journal-title":"Neoplasia"},{"key":"1858_CR213","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.xcrm.2026.102713","volume":"7","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Wu D, Chen R, Zhai M, Yang F, Wang J, et al. Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancer. Cell Rep Med. 2026;7:102713.","journal-title":"Cell Rep Med"},{"key":"1858_CR214","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-024-01596-9","volume":"17","author":"X Liu","year":"2024","unstructured":"Liu X, Peng T, Xu M, Lin S, Hu B, Chu T, et al. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications. J Hematol Oncol. 2024;17:72.","journal-title":"J Hematol Oncol"},{"key":"1858_CR215","doi-asserted-by":"crossref","first-page":"e2305724","DOI":"10.1002\/advs.202305724","volume":"11","author":"X Bian","year":"2024","unstructured":"Bian X, Wang W, Abudurexiti M, Zhang X, Ma W, Shi G, et al. Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity. Adv Sci (Weinh). 2024;11:e2305724.","journal-title":"Adv Sci (Weinh)"},{"key":"1858_CR216","doi-asserted-by":"crossref","first-page":"e010183","DOI":"10.1136\/jitc-2024-010183","volume":"13","author":"X Song","year":"2025","unstructured":"Song X, Zhu Y, Geng W, Jiao J, Liu H, Chen R, et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer. 2025;13:e010183.","journal-title":"J Immunother Cancer"},{"key":"1858_CR217","doi-asserted-by":"crossref","first-page":"958360","DOI":"10.3389\/fimmu.2022.958360","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Kong Y, Dang Q, Weng S, Zheng Y, Ren Y, et al. Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application. Front Immunol. 2022;13:958360.","journal-title":"Front Immunol"},{"key":"1858_CR218","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/cells10020212","volume":"10","author":"C Keup","year":"2021","unstructured":"Keup C, Suryaprakash V, Storbeck M, Hoffmann O, Kimmig R, Kasimir-Bauer S. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients. Cells. 2021;10:212.","journal-title":"Cells"},{"key":"1858_CR219","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41416-023-02491-9","volume":"130","author":"SZ Eslami","year":"2024","unstructured":"Eslami SZ, Cortes-Hernandez LE, Sinoquet L, Gauthier L, Vautrot V, Cayrefourcq L, et al. Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer. Br J Cancer. 2024;130:63\u201372.","journal-title":"Br J Cancer"},{"key":"1858_CR220","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wu H, Chong W, Shang L, Jing C, Li L. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death Dis. 2022;13:903.","journal-title":"Cell Death Dis"},{"key":"1858_CR221","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-025-01733-y","volume":"18","author":"C Yang","year":"2025","unstructured":"Yang C, Liu C, Xia C, Fu L. Clinical applications of circulating tumor cells in metastasis and therapy. J Hematol Oncol. 2025;18:80.","journal-title":"J Hematol Oncol"},{"key":"1858_CR222","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1021\/acsnano.4c13599","volume":"19","author":"A Salviano-Silva","year":"2025","unstructured":"Salviano-Silva A, Wollmann K, Brenna S, Reimer R, Neumann JE, Dottermusch M, et al. Extracellular Vesicles Carrying Tenascin-C are Clinical Biomarkers and Improve Tumor-Derived DNA Analysis in Glioblastoma Patients. ACS Nano. 2025;19:9844\u201359.","journal-title":"ACS Nano"},{"key":"1858_CR223","doi-asserted-by":"crossref","first-page":"e18584","DOI":"10.1002\/advs.202518584","volume":"13","author":"J Zhang","year":"2026","unstructured":"Zhang J, Huang X, Ma L, Chen Z, Li T, Wang L, et al. Micro-Organ Chip Deciphers Tumor-Derived G-CSF as Remote Commander of Lung Pre-Metastatic Niche via VEGFA-KDR Cascade. Adv Sci (Weinh). 2026;13:e18584.","journal-title":"Adv Sci (Weinh)"},{"key":"1858_CR224","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/s41551-025-01428-2","volume":"9","author":"C Ma","year":"2025","unstructured":"Ma C, Wang H, Liu L, Chen R, Mukherjee N, Tong J, et al. Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia. Nat Biomed Eng. 2025;9:2098\u2013114.","journal-title":"Nat Biomed Eng"},{"key":"1858_CR225","doi-asserted-by":"crossref","first-page":"121728","DOI":"10.1016\/j.biomaterials.2022.121728","volume":"288","author":"LI Ibrahim","year":"2022","unstructured":"Ibrahim LI, Hajal C, Offeddu GS, Gillrie MR, Kamm RD. Omentum-on-a-chip: A multicellular, vascularized microfluidic model of the human peritoneum for the study of ovarian cancer metastases. Biomaterials. 2022;288:121728.","journal-title":"Biomaterials"},{"key":"1858_CR226","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.mtbio.2019.100040","volume":"5","author":"R Spelat","year":"2020","unstructured":"Spelat R, Ferro F, Contessotto P, Warren NJ, Marsico G, Armes SP, et al. A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells. Mater Today Bio. 2020;5:100040.","journal-title":"Mater Today Bio"},{"key":"1858_CR227","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1158\/0008-5472.CAN-23-0398","volume":"83","author":"D Miroshnychenko","year":"2023","unstructured":"Miroshnychenko D, Miti T, Kumar P, Miller A, Laurie M, Giraldo N, et al. Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles. Cancer Res. 2023;83:3681\u201392.","journal-title":"Cancer Res"},{"key":"1858_CR228","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","volume":"4","author":"JL Chitty","year":"2023","unstructured":"Chitty JL, Yam M, Perryman L, Parker AL, Skhinas JN, Setargew YFI, et al. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nat Cancer. 2023;4:1326\u201344.","journal-title":"Nat Cancer"},{"key":"1858_CR229","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020;11:2416.","journal-title":"Nat Commun"},{"key":"1858_CR230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. Annu Rev Pathol. 2023;18:123\u201348.","journal-title":"Annu Rev Pathol"},{"key":"1858_CR231","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.drup.2020.100715","volume":"53","author":"N Erin","year":"2020","unstructured":"Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat. 2020;53:100715.","journal-title":"Drug Resist Updat"},{"key":"1858_CR232","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"1858_CR233","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-025-02312-y","volume":"24","author":"H Umeda","year":"2025","unstructured":"Umeda H, Shigeyasu K, Takahashi T, Moriwake K, Kondo Y, Yoshida K, et al. ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer. Mol Cancer. 2025;24:116.","journal-title":"Mol Cancer"},{"key":"1858_CR234","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40164-024-00532-4","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Li JJ. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression. Exp Hematol Oncol. 2024;13:64.","journal-title":"Exp Hematol Oncol"},{"key":"1858_CR235","doi-asserted-by":"crossref","first-page":"101231","DOI":"10.1016\/j.xcrm.2023.101231","volume":"4","author":"P Qin","year":"2023","unstructured":"Qin P, Chen H, Wang Y, Huang L, Huang K, Xiao G, et al. Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics. Cell Rep Med. 2023;4:101231.","journal-title":"Cell Rep Med"},{"key":"1858_CR236","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-026-02598-6","volume":"25","author":"M Zhang","year":"2026","unstructured":"Zhang M, Zhang X, Song X, Bai R, Qiao Q, Wei M, et al. Spatiotemporal dynamics of radioresistance: decoding macrophage-driven radioprotective niches through temporal-spatial reprogramming. Mol Cancer. 2026;25:94.","journal-title":"Mol Cancer"},{"key":"1858_CR237","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1470-2045(25)00099-3","volume":"26","author":"R Srinivasan","year":"2025","unstructured":"Srinivasan R, Iliopoulos O, Beckermann KE, Narayan V, Maughan BL, Oudard S, et al. Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study. Lancet Oncol. 2025;26:571\u201382.","journal-title":"Lancet Oncol"},{"key":"1858_CR238","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11912-022-01354-5","volume":"25","author":"WW Choi","year":"2023","unstructured":"Choi WW, Boland JL, Kalola A, Lin J. Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors. Curr Oncol Rep. 2023;25:123\u201329.","journal-title":"Curr Oncol Rep"},{"key":"1858_CR239","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1200\/JCO.2014.55.7504","volume":"33","author":"MJ Borad","year":"2015","unstructured":"Borad MJ, Reddy SG, Bahary N, Uronis HE, Sigal D, Cohn AL, et al. Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. J Clin Oncol. 2015;33:1475\u201381.","journal-title":"J Clin Oncol"},{"key":"1858_CR240","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1470-2045(17)30381-9","volume":"18","author":"WD Tap","year":"2017","unstructured":"Tap WD, Papai Z, Van Tine BA, Attia S, Ganjoo KN, Jones RL, et al. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406\/SARC021): an international, multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2017;18:1089\u2013103.","journal-title":"Lancet Oncol"},{"key":"1858_CR241","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-20-4118","volume":"27","author":"A Hegde","year":"2021","unstructured":"Hegde A, Jayaprakash P, Couillault CA, Piha-Paul S, Karp D, Rodon J, et al. A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies. Clin Cancer Res. 2021;27:3050\u201360.","journal-title":"Clin Cancer Res"},{"key":"1858_CR242","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-Mediated Metastasis: Communication from a Distance. Dev Cell. 2019;49:347\u201360.","journal-title":"Dev Cell"},{"key":"1858_CR243","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.cmet.2025.08.009","volume":"37","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Xu Y, Wang H, Yang F, Ding XH, Fu T, et al. HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer. Cell Metab. 2025;37:2030\u2013e477.","journal-title":"Cell Metab"},{"key":"1858_CR244","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41556-025-01660-7","volume":"27","author":"N Abeysundara","year":"2025","unstructured":"Abeysundara N, Rasnitsyn A, Fong V, Bahcheli A, Van Ommeren R, Juraschka K, et al. Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth. Nat Cell Biol. 2025;27:863\u201374.","journal-title":"Nat Cell Biol"},{"key":"1858_CR245","doi-asserted-by":"crossref","first-page":"1838169","DOI":"10.3389\/fimmu.2026.1838169","volume":"17","author":"M Mourad","year":"2026","unstructured":"Mourad M, Al Mahmasani L, Abbas N, Shamseddine A. Organ-specific pre-metastatic and metastatic niches in colorectal cancer: discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis. Front Immunol. 2026;17:1838169.","journal-title":"Front Immunol"},{"key":"1858_CR246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, et al. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol. 2020;38:1\u201310.","journal-title":"J Clin Oncol"},{"key":"1858_CR247","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-25-2944","volume":"32","author":"HJ Cho","year":"2026","unstructured":"Cho HJ, Kwon M, Varner JA. Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma. Clin Cancer Res. 2026;32:1196\u2013209.","journal-title":"Clin Cancer Res"},{"key":"1858_CR248","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","volume":"184","author":"S Kaczanowska","year":"2021","unstructured":"Kaczanowska S, Beury DW, Gopalan V, Tycko AK, Qin H, Clements ME, et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 2021;184:2033\u2013e5221.","journal-title":"Cell"},{"key":"1858_CR249","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.2147\/IJN.S513688","volume":"20","author":"G Lee","year":"2025","unstructured":"Lee G, Kim J, Yang J, Jang Y, Jang J, Tanaka M, et al. FOLR1-Targeted Oxygen-Delivering Nanosomes Enhance Chemo-Induced Apoptosis in Hypoxic Cancer. Int J Nanomed. 2025;20:6875\u201389.","journal-title":"Int J Nanomed"},{"key":"1858_CR250","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller JG, Cole SW, Crone EM, Byrne DJ, Shackleford DM, Pang JB, et al. Preoperative beta-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial. Clin Cancer Res. 2020;26:1803\u201311.","journal-title":"Clin Cancer Res"},{"key":"1858_CR251","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","volume":"119","author":"D Melisi","year":"2018","unstructured":"Melisi D, Garcia-Carbonero R, Macarulla T, Pezet D, Deplanque G, Fuchs M, et al. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Br J Cancer. 2018;119:1208\u201314.","journal-title":"Br J Cancer"},{"key":"1858_CR252","doi-asserted-by":"crossref","first-page":"e002068","DOI":"10.1136\/jitc-2020-002068","volume":"9","author":"D Melisi","year":"2021","unstructured":"Melisi D, Oh DY, Hollebecque A, Calvo E, Varghese A, Borazanci E, et al. Safety and activity of the TGF\u03b2 receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. J Immunother Cancer. 2021;9:e002068.","journal-title":"J Immunother Cancer"},{"key":"1858_CR253","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2213614","volume":"388","author":"P Rodriguez-Otero","year":"2023","unstructured":"Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, et al. Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma. N Engl J Med. 2023;388:1002\u201314.","journal-title":"N Engl J Med"},{"key":"1858_CR254","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","volume":"398","author":"JG Berdeja","year":"2021","unstructured":"Berdeja JG, Madduri D, Usmani SZ, Jakubowiak A, Agha M, Cohen AD, et al. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study. Lancet. 2021;398:314\u201324.","journal-title":"Lancet"},{"key":"1858_CR255","doi-asserted-by":"crossref","first-page":"e13273","DOI":"10.1111\/sji.13273","volume":"98","author":"D Gao","year":"2023","unstructured":"Gao D, Hong F, He A. The role of bone marrow microenvironment on CAR-T efficacy in haematologic malignancies. Scand J Immunol. 2023;98:e13273.","journal-title":"Scand J Immunol"},{"key":"1858_CR256","doi-asserted-by":"crossref","first-page":"109795","DOI":"10.1016\/j.isci.2024.109795","volume":"27","author":"KP Ko","year":"2024","unstructured":"Ko KP, Zhang S, Huang Y, Kim B, Zou G, Jun S, et al. Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer. iScience. 2024;27:109795.","journal-title":"iScience"},{"key":"1858_CR257","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","volume":"385","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, et al. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021;385:2036\u201346.","journal-title":"N Engl J Med"},{"key":"1858_CR258","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","volume":"379","author":"MR Smith","year":"2012","unstructured":"Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, et al. Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet. 2012;379:39\u201346.","journal-title":"Lancet"},{"key":"1858_CR259","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W, Shimizu K, Garcia-Sanz R, Durie B, et al. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018;19:370\u201381.","journal-title":"Lancet Oncol"},{"key":"1858_CR260","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S1470-2045(22)00290-X","volume":"23","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Powles T, Burotto M, Escudier B, Bourlon MT, Shah AY, et al. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23:888\u201398.","journal-title":"Lancet Oncol"},{"key":"1858_CR261","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1080\/10428194.2019.1643463","volume":"60","author":"LA Andritsos","year":"2019","unstructured":"Andritsos LA, Byrd JC, Cheverton P, Wu J, Sivina M, Kipps TJ, et al. A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2019;60:3461\u201369.","journal-title":"Leuk Lymphoma"},{"key":"1858_CR262","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00262-020-02844-w","volume":"70","author":"MM Melssen","year":"2021","unstructured":"Melssen MM, Pollack KE, Meneveau MO, Smolkin ME, Pinczewski J, Koeppel AF, et al. Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials. Cancer Immunol Immunother. 2021;70:2151\u201364.","journal-title":"Cancer Immunol Immunother"},{"key":"1858_CR263","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","volume":"15","author":"RG Everson","year":"2024","unstructured":"Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, et al. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat Commun. 2024;15:3882.","journal-title":"Nat Commun"},{"key":"1858_CR264","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41586-026-10157-8","volume":"653","author":"G Skrupskelyte","year":"2026","unstructured":"Skrupskelyte G, Rojo Arias JE, Ajith H, Dang Y, Rossetti D, Han S, et al. Precancerous niche remodelling dictates nascent tumour persistence. Nature. 2026;653:242\u201353.","journal-title":"Nature"},{"key":"1858_CR265","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382.","journal-title":"J Hepatol"},{"key":"1858_CR266","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","volume":"186","author":"B Ruf","year":"2023","unstructured":"Ruf B, Bruhns M, Babaei S, Kedei N, Ma L, Revsine M, et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell. 2023;186:3686\u2013e70532.","journal-title":"Cell"},{"key":"1858_CR267","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stem.2018.11.016","volume":"23","author":"M Fujii","year":"2018","unstructured":"Fujii M, Matano M, Toshimitsu K, Takano A, Mikami Y, Nishikori S, et al. Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition. Cell Stem Cell. 2018;23:787\u2013e936.","journal-title":"Cell Stem Cell"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01858-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:47:53Z","timestamp":1792190873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01858-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":267,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01858-8","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"25 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}